Company news

GE HealthCare Technologies Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite

May 14, 2025

GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology

May 13, 2025

GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent

May 12, 2025

GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system

May 11, 2025

ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions

May 2, 2025

GE HealthCare reports first quarter 2025 financial results

April 29, 2025

GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium

April 24, 2025

GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

April 8, 2025

GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan

March 30, 2025

GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions

March 27, 2025

GE HealthCare announces cash dividend for first quarter of 2025

March 26, 2025

ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway

March 26, 2025

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts

March 19, 2025

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions

March 17, 2025

GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures

March 16, 2025

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Portfolio to Improve Speed of Digital Innovation Adoption

March 3, 2025

GE HealthCare names new president and CEO, China

February 26, 2025

GE HealthCare unveils Freelium, a next-generation sealed magnet platform at ECR 2025 to support equitable and sustainable access to MR

February 25, 2025

Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection

February 24, 2025

GE HealthCare reports fourth quarter and full year 2024 financial results

February 12, 2025

GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand

January 30, 2025

GE HealthCare named to 2025 Fortune World’s Most Admired Companies™ list

January 28, 2025

GE HealthCare unveils enhanced Voluson Expert Series women’s health ultrasound systems with focus on early detection and exam efficiency

January 27, 2025

University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology

January 14, 2025

GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide

December 4, 2024

GE HealthCare showcases commitment to sustainable innovation at RSNA 2024

December 3, 2024

GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction

December 2, 2024

GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI

November 30, 2024

GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

November 30, 2024

GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care

November 25, 2024

GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology

November 21, 2024

GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth

November 20, 2024

GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System

November 12, 2024

GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage

November 11, 2024

GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™

November 10, 2024

GE HealthCare to Host its 2024 Investor Day on November 21

November 6, 2024

GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares

November 6, 2024

GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares

November 6, 2024

GE HealthCare reports third quarter 2024 financial results

October 29, 2024

GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view

October 20, 2024

GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects

October 20, 2024

GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes

October 17, 2024

GE HealthCare announces major academic medical center as first customer to adopt new Hospital Pulse Tile for Command Center

October 16, 2024

A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine

October 15, 2024

GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system

October 13, 2024

GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging

October 8, 2024

GE HealthCare to announce third quarter 2024 results on October 30, 2024

October 7, 2024

GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe

October 6, 2024

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

October 6, 2024

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

September 26, 2024

← Newer news releases · Older news releases →

Calls

The 5 newest of 16 calls. Every call is listed under its year.

Decks

The 5 newest of 40 decks. Every deck is listed under its year.